Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2000Journal of Clinical InvestigationOpen Access

Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis

View Full Paper
Ask AI
Bookmark
Share

Authors

YKYubin KangChangchun University of Science and TechnologyEZElias T. ZambidisJohns Hopkins UniversityDSDavid W. ScottBC Cancer Agency

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kang et al. (2000) studied this question.

synapsesocial.com/papers/6a950bfba46e9aa31f0f2a3ahttps://doi.org/10.1172/jci9168
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neonatal Exposure to a Self-Peptide–Immunoglobulin Chimera Circumvents the Use of Adjuvant and Confers Resistance to Autoimmune Disease by a Novel Mechanism Involving Interleukin 4 Lymph Node Deviation and Interferon γ–mediated Splenic Anergy1998 · 41 citations
  2. 2Endogenous IL-12 Is Required for Induction and Expression of Experimental Autoimmune Uveitis1998 · 112 citations
  3. 3Determinant Spreading Associated with Demyelination in a Nonhuman Primate Model of Multiple Sclerosis1999 · 75 citations
  4. 4Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis2000 · 44 citations